Erratum: miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer

Erratum to: Transl Cancer Res 2022;11:3803-13.

In the published article entitled “miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer” (Transl Cancer Res 2022;11:3803-13. doi: 10.21037/tcr-22-2177) (1), Figure 2C was published incorrectly. The updated version of Figure 2 and the legend of Figure 2 is provided below. The authors apologize for any inconvenience that it may have caused.

Figure 2 Effect of miR-137 on migration and invasion of non-small cell lung cancer (NSCLC) cells by transwell assay. (A) Expression of miR-137 in NSCLC cell line A549 or H1299 after transfection with miR-137 mimic or inhibitor. (B) Effect of miR-137 on migration and invasion of A549 cells. Stained with Giemsa. 100×. (C) Effect of miR-137 on migration and invasion of H1299 cells. Stained with Giemsa. 200×. *, P<0.05 and **, P<0.01 versus negative control.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Luo Y, Hu S, Wang F, et al. miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer. Transl Cancer Res 2022;11:3803-13. [Crossref] [PubMed]